Package 51672-4254-6

{"route": ["ORAL"], "spl_id": "4a8e8fa1-70f9-ff7a-e063-6294a90a6e45", "openfda": {"nui": ["N0000175753", "N0000008486", "N0000175751", "N0000187061", "N0000000191"], "unii": ["U3H27498KS"], "rxcui": ["103968", "198430", "252478", "252479"], "spl_set_id": ["83297e2e-9199-4b3d-9f44-a921787758fe"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]", "Mood Stabilizer [EPC]"], "pharm_class_moa": ["Organic Cation Transporter 2 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (51672-4254-6)", "package_ndc": "51672-4254-6", "marketing_start_date": "20260301"}], "brand_name": "LAMOTRIGINE", "product_id": "51672-4254_4a8e8fa1-70f9-ff7a-e063-6294a90a6e45", "dosage_form": "TABLET", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Dihydrofolate Reductase Inhibitors [MoA]", "Mood Stabilizer [EPC]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "product_ndc": "51672-4254", "generic_name": "lamotrigine", "labeler_name": "Sun Pharmaceutical Industries, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LAMOTRIGINE", "active_ingredients": [{"name": "LAMOTRIGINE", "strength": "100 mg/1"}], "application_number": "ANDA219677", "marketing_category": "ANDA", "marketing_start_date": "20260301", "listing_expiration_date": "20271231"}